Insufficient scRNA-seq data for expression of GPC2 at tissue level.
Tissue | GTEx Coverage  | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 160.66 | 2620 / 2642 | 98% | 19.57 | 688 / 705 |
| skin | 98% | 587.91 | 1772 / 1809 | 74% | 5.85 | 348 / 472 |
| uterus | 100% | 300.81 | 170 / 170 | 66% | 6.50 | 301 / 459 |
| bladder | 100% | 111.05 | 21 / 21 | 46% | 4.25 | 231 / 504 |
| ovary | 100% | 274.14 | 180 / 180 | 40% | 2.53 | 173 / 430 |
| breast | 96% | 138.45 | 440 / 459 | 33% | 2.12 | 372 / 1118 |
| intestine | 98% | 141.94 | 944 / 966 | 22% | 0.77 | 118 / 527 |
| lung | 86% | 78.69 | 495 / 578 | 34% | 2.14 | 390 / 1155 |
| prostate | 98% | 134.64 | 241 / 245 | 14% | 0.54 | 71 / 502 |
| esophagus | 84% | 70.37 | 1208 / 1445 | 17% | 0.84 | 32 / 183 |
| spleen | 100% | 199.80 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.53 | 1 / 1 |
| adrenal gland | 76% | 48.54 | 196 / 258 | 18% | 0.72 | 41 / 230 |
| adipose | 92% | 94.68 | 1103 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 70% | 50.21 | 458 / 653 | 14% | 2.30 | 86 / 605 |
| stomach | 61% | 39.53 | 218 / 359 | 18% | 0.67 | 51 / 286 |
| peripheral blood | 75% | 90.51 | 696 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 4.12 | 33 / 45 |
| kidney | 64% | 49.36 | 57 / 89 | 6% | 0.21 | 54 / 901 |
| blood vessel | 64% | 50.71 | 851 / 1335 | 0% | 0 | 0 / 0 |
| heart | 62% | 41.46 | 536 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 23% | 15.21 | 77 / 328 | 15% | 0.87 | 26 / 178 |
| muscle | 33% | 22.41 | 261 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 2.12 | 7 / 29 |
| liver | 5% | 3.12 | 11 / 226 | 3% | 0.12 | 12 / 406 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009966 | Biological process | regulation of signal transduction |
| GO_0030182 | Biological process | neuron differentiation |
| GO_0007224 | Biological process | smoothened signaling pathway |
| GO_0016477 | Biological process | cell migration |
| GO_0010976 | Biological process | positive regulation of neuron projection development |
| GO_1905475 | Biological process | regulation of protein localization to membrane |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0009986 | Cellular component | cell surface |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0098552 | Cellular component | side of membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0045202 | Cellular component | synapse |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GPC2 |
| Protein name | Glypican-2 [Cleaved into: Secreted glypican-2] Glypican 2 |
| Synonyms | |
| Description | FUNCTION: Cell surface proteoglycan that bears heparan sulfate. May fulfill a function related to the motile behaviors of developing neurons (By similarity). . FUNCTION: Cell surface proteoglycan. . |
| Accessions | Q8N158 A0A0J9YXG7 ENST00000480087.5 ENST00000292377.4 |
